| Scientific Name |
Fingolimod
|
|---|---|
| Brand Name |
Gilenya
|
| Risk |
Safety information about contraindication in pregnant women and in women of childbearing potential not using effective contraception, Communication on progressive multifocal leukoencephalopathy (PML) , Hemophagocytic syndrome (HPS), Cardiovascular, Adverse Events after the First Dose, Slow heart rate and irregular heartbeat, Instructions for proper use, Updated recommendations to minimize the risk of drug-induced liver injury (DILI).
|
| Educational Materials for Healthcare Professionals |
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|
| Safety Communication for Healthcare Professionals |
|
| Educational Materials for Patients |
|